Abstract Background and objective: Delivering therapeutic drugs to the brain for neurological disorders remains challenging due to the restrictive nature…
Abstract Background: Comparative bioavailability of cannabinoids following their administration by dosing routes has been studied previously, but there are no…
Abstract Melatonin, insulin, and Δ9-tetrahydrocannabinol (THC) have been shown to reverse cognitive deficits and attenuate neuropathologies in transgenic mouse models…
Abstract A major obstacle to fulfilling the therapeutic promise of gene therapies for hereditary brain diseases, such as Huntington’ Disease…
Abstract THC has been used as a promising treatment approach for neurological disorders, but the highly psychoactive effects have largely…